Updates on the Management of Ocular Vasculopathies with VEGF Inhibitor Conbercept-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Updates on the Management of Ocular Vasculopathies with VEGF Inhibitor Conbercept

Published:2020-07-07 Issue:12 Volume:45 Page:1467-1476
ISSN:0271-3683
Container-title:Current Eye Research
language:en
Short-container-title:Current Eye Research

Author:

Liu Huan¹²,Ma Yue¹,Xu Hong-Chang¹,Huang Li-Ying¹,Zhai Li-Ying¹³,Zhang Xiao-Rong¹²^ORCID

Affiliation:

1. Division of Ocular Injuries, Department of Ophthalmology, The Third Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, China

2. Hebei OPO Eye Bank, The Third Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, China

3. Department of Ophthalmology, Cangzhou Central Hospital, Cangzhou, Hebei, China

Funder

Bureau of Science and Technology of Hebei Province

The Bureau of Science and Technology of Hebei Province

Publisher

Informa UK Limited

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Link

https://www.tandfonline.com/doi/pdf/10.1080/02713683.2020.1781193

Reference130 articles.

1. The biology of VEGF and its receptors

2. Vascular endothelial growth factor (VEGF) and its receptors

3. INTRAVITREAL CONBERCEPT (KH902) FOR SURGICAL TREATMENT OF SEVERE PROLIFERATIVE DIABETIC RETINOPATHY

4. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

5. AGE-RELATED MACULAR DEGENERATION–ASSOCIATED PERIPAPILLARY CHOROIDAL NEOVASCULARIZATION IN THE ERA OF ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic factors for intravitreal conbercept in the treatment of choroidal neovascularization secondary to pathological myopia;International Ophthalmology;2024-06-22

2. Kavain Alleviates Choroidal Neovascularization Via Decreasing the Activity of the HIF-1α/VEGF-A/VEGFR2 Signaling Pathway and Inhibiting Inflammation;Advanced Pharmaceutical Bulletin;2024-03-11

3. Hemorrhagic retinal arterial macroaneurysm combined with branch retinal artery occlusion treated with intravitreal conbercept injection: A case report;Medicine;2023-10-27

4. Clinical outcomes of different regimens of intravitreal Conbercept for the treatment of choroidal neovascularization secondary to pathological myopia;International Ophthalmology;2023-08-10

5. Long-term clinical effects of intravitreal injections of conbercept for the treatment of choroidal neovascularization in patients with pathological myopia;International Journal of Ophthalmology;2022-12-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3